Michael S Perry sold $1M of ARWR stock

Michael S Perry, Dir of Arrowhead Pharmaceuticals, Inc. (ARWR), sold 11,600 shares of ARWR stock worth $1M, per an SEC Form 4 filed Aug 20, 2026.

It was an open-market sale.

The trade happened on Aug 18, 2026, 2 days before it was made public.

ARWR has moved -45.6% since the trade date, from $87.90 to $47.78 (Nov 13, 2026 close).